Description and Brand Names
Drug information provided by: IBM Micromedex
US Brand Name
- Orkambi
Descriptions
Lumacaftor and ivacaftor combination is used to treat cystic fibrosis (CF) in patients 2 years of age and older. It is only used for patients who have two copies of F508del mutation in their CF transmembrane conductance regulator (CFTR) gene. Your doctor will use a test to check for the mutation before you receive the medicine.
This medicine is available only with your doctor's prescription.
This product is available in the following dosage forms:
Portions of this document last updated: July 01, 2019
Copyright © 2019 IBM Watson Health. All rights reserved. Information is for End User's use only and may not be sold, redistributed or otherwise used for commercial purposes.